Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IBB vs PBE overlap: 36% of top holdings shared

Bottom line

How much do IBB and PBE overlap?

36% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 44.4% of IBB's assets and 46.8% of PBE's. They share a meaningful core but differ in the rest of the portfolio.

IBB holds far more positions (254 vs 33), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

IBBPBE
Weight overlap (top 25)36%
Shared holdings12
Weight in shared holdings44.4%46.8%
Total positions25433
Expense ratio0.44%0.59%
Holdings as ofSep 30, 2025Jul 31, 2026

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Holdings IBB and PBE have in common

Holding% of IBB% of PBEOverlap
Vertex Pharmaceuticals, Inc.7.66%4.99%4.99%
Gilead Sciences, Inc.7.52%4.43%4.43%
Amgen, Inc.7.50%5.22%5.22%
Regeneron Pharmaceuticals, Inc.5.70%5.47%5.47%
Alnylam Pharmaceuticals, Inc.5.68%3.17%3.17%
Biogen, Inc.2.03%4.79%2.03%
United Therapeutics Corp.1.82%4.08%1.82%
Incyte Corp.1.62%3.06%1.62%
Illumina, Inc.1.41%3.51%1.41%
Neurocrine Biosciences, Inc.1.34%2.66%1.34%
Exelixis, Inc.1.07%2.64%1.07%
BioMarin Pharmaceutical, Inc.1.02%2.82%1.02%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. IQVIA Holdings, Inc. — 3.18%
  3. Argenx SE — 3.15%
  4. Insmed, Inc. — 2.95%
  5. Mettler-Toledo International, Inc. — 2.49%
  6. Natera, Inc. — 2.11%
  7. BeOne Medicines Ltd. — 2.11%
  8. Waters Corp. — 1.77%
  9. Genmab A/S — 1.38%
  10. Medpace Holdings, Inc. — 1.16%
  11. Ionis Pharmaceuticals, Inc. — 1.03%
  12. Madrigal Pharmaceuticals, Inc. — 0.92%
  13. Moderna, Inc. — 0.88%

Only in PBE

  1. Invesco Private Prime Fund — 12.89%
  2. CareDx, Inc. — 5.04%
  3. Invesco Private Government Fund — 4.97%
  4. Royalty Pharma PLC — 4.94%
  5. Bio-Techne Corp. — 3.73%
  6. Protagonist Therapeutics, Inc. — 3.40%
  7. Vericel Corp. — 3.27%
  8. Repligen Corp. — 3.04%
  9. Acadia Pharmaceuticals Inc. — 3.02%
  10. Halozyme Therapeutics, Inc. — 2.98%
  11. Qiagen N.V. — 2.89%
  12. BioCryst Pharmaceuticals, Inc. — 2.63%
  13. Veracyte, Inc. — 2.60%

Asset mix

Asset typeIBBPBE
Stocks99.8%100.1%
Cash & short-term funds13.4%17.9%

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Country mix

CountryIBBPBE
US98.6%108.6%
GB1.0%4.9%
NL4.3%2.9%
CH2.7%—
DK2.2%—
KY0.9%1.6%
DE0.7%—
BM0.7%—

Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)

Check another pair

FAQ

How much do IBB and PBE overlap?
About 36% by weight. 12 securities appear in both funds' top 25 holdings; they make up 44.4% of IBB's assets and 46.8% of PBE's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IBB and PBE have in common?
The largest shared holdings are Regeneron Pharmaceuticals, Inc., Amgen, Inc., Vertex Pharmaceuticals, Inc., Gilead Sciences, Inc., Alnylam Pharmaceuticals, Inc..
Should I own both IBB and PBE?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IBB or PBE?
IBB is broader, with 254 positions versus 33 for PBE. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.